← Compare landing
Omniabio vs Pluri
Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.
| Category | Omniabio | Pluri |
|---|---|---|
| Summary | OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages. | Full-service CDMO specializing in cell therapy manufacturing with GMP facilities, proprietary packed-bed expansion technology, and regulatory approvals from FDA, EMA, PMDA, and other key agencies for clinical-stage production. |
| Services |
|
|
| Modalities |
|
|
| Development capabilities |
|
|
| Manufacturing capabilities |
|
|
| Locations |
|
|
| Certifications | Data not yet provided. |
|
Find similar companies
Markdown mirror: /compare/omniabio/pluri-biotech.md